Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03741257
Other study ID # N-55-2018
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 1, 2018
Est. completion date February 2020

Study information

Verified date November 2018
Source Cairo University
Contact Rasha Behery, MD
Phone +201228604556
Email rasha.behery.rz@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background and Rationale :

Perioperative fluid management is a challenging issue in surgical care especially in a procedure specific model. Recently hypertonic saline (HS) has the advantage of using the patient's own total body water by drawing interstitial space. Although it still controversial whether HS is associated with benefits in specific patient populations, particularly with respect to site of lesion and illness severity; these data provide insight into therapeutic modalities to curtail ileus formation.

Objectives :

- Measurement of total volume of fluid infused, the need of inotropic or vasopressor to maintain adequate hemodynamic parameters with assessment of electrolyte disturbances and S.lactate

- The incidence rate of surgical complications; infection and anastomotic dehiscence

Study population & Sample size :

There were no previous trials comparing the two studied groups of the current trial. We expected a small standardized effect size of 0.2. Based on this effect size, 25 subjects will be needed to elicit the difference between the two groups at an alpha level of 0.05 and power of 0.9 (Whitehead et al; 2016).


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date February 2020
Est. primary completion date November 2019
Accepts healthy volunteers No
Gender All
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria:

- Age: 20-70 years old

- ASA=III

- BMI 25-40kg/m.

Exclusion Criteria:

- Severe CVS diseases (EF<50%)

- Severe pulmonary diseases (Pulmonary function test = 50% of predicted)

- Neurological disorders; Psychological diseases, demyelinating lesions, Parkinsonism, motor or sensory disorders.

- Pregnancy.

- Severe chronic renal disease (s. Creatinine> 2gm/dl or patients on dialysis).

- Severe hepatic impairment (Child & Pugh classification class C).

- Acid-base and electrolytes disturbances.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Hypertonic saline
resuscitation fluid

Locations

Country Name City State
Egypt Cairo University Hospitals Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Total volume of infused fluids the total volume of fluids given to subjects intraoperatively and postoperatively 24 hours
Secondary surgical complications rate the rate of surgical complications i.e leakage and wound dehisence 4 days